BioBam Bioinformatics
Private Company
Funding information not available
Overview
BioBam is a private, revenue-generating bioinformatics software company that has established itself as a key enabler for non-bioinformatician researchers. Its core product, OmicsBox, is a modular desktop application for functional genomics, transcriptomics, genetic variation, metagenomics, and genome analysis, used by over 900 institutions worldwide. The company complements this with OmicsCloud, a managed AWS-based cloud platform for scalable, high-performance computing. BioBam operates on a platform business model, selling software subscriptions and cloud compute services to academic and industrial research labs.
Technology Platform
OmicsBox: A desktop bioinformatics suite with a graphical user interface for end-to-end analysis of genomes, transcriptomes, and metagenomes. OmicsCloud: A managed AWS-based cloud platform providing scalable, secure, and cost-efficient high-performance computing for bioinformatics pipelines.
Opportunities
Risk Factors
Competitive Landscape
BioBam competes in the commercial bioinformatics software market against companies like Qiagen (CLC Genomics Workbench), DNAnexus, and Partek, as well as open-source frameworks like Galaxy. Its key differentiation is a strong focus on user-friendliness and an integrated, end-to-end workflow for specific omics applications, targeting the non-expert researcher segment.